Lichen planus (LP) is one of the most common idiopathic immune disorders, found in 0.5-2.3% (1) of the general population. LP may involve, separately or simultaneously, different muco-cutaneous sites (oral and genital mucosa, skin, scalp and nail). The concurrent involvement of oral and genital sites, in patients with mucosal burning and itching, has been reported, especially in females, usually showing a low percentage (3.7-19 .3%) of double involvement for LP (2) (3) (4) .
It is common for women in the general population, to present to healthcare providers with the non-specific symptoms of persistent and recurrent oral and/or genital burning infection, oral lichen planus (OLP), burning mouth syndrome, or drug-related conditions. Similarly, genital burning may be attributed to candidosis (5) , desquamative inflammatory vaginitis (6) , or dysaesthetic vulvodynia (7) . Collectively, these symptoms are often misdiagnosed, particularly since biopsies are not performed on a regular basis (8) .
In 1869, Wilson (9) described a case of a woman with LP and "pruritus vaginae"; more recently, Gardner (10) and Lynch (11) reported a "desquamative inflammatory vaginitis" in association with erosive OLP. This association was recognized and defined as "vulvo-vaginalgingival syndrome" (12) or "plurimucosal LP" (13) , and later its prevalence was established as between 3.7% and 19.3% in patients with OLP (2) .
The main aims of this cross-sectional study were: (i) to evaluate the frequency of genital (vulval) LP (VLP) and vulval lichen sclerosus (VLS) in females affected by OLP; (ii) to verify whether any demographic, clinical, or histological features of OLP are associated with a higher risk of genital involvement.
PATIENTS AND METHODS
Between October 2001 and April 2004, following informed consent, female out-patients with clinical signs of oral lichenoid lesions were consecutively enrolled after histological confirmation of OLP. Patients were excluded, if on the basis of histopathological features and clinical data, they were found to have lichenoid reactions to medications or a dental material (e.g. amalgam).
Oral examination and diagnostic criteria
Anamnestic and clinical data for each patient was recorded on a clinical report form. Examinations were carried out by one of the authors (ODF) as described previously (14) (15) . Clinical features of OLP lesions were classified, as proposed by Rogers & Eisen (4) , on the basis of the dominant variant into three forms: reticular, athrophic-erythematous, and ulcerative (including bullous) (Fig. 1) .
Gynaecological examination and diagnostic criteria
After the histological confirmation of OLP, all patients (with or without genital symptoms) were evaluated by a trained vulvologist-gynaecologist (PB), as recommended by the European College for the Study of Vulval Diseases (ECSVD) (16 medical history, genital symptoms, clinical and histological data were collected and recorded on a vulvologist's chart. Genital symptoms were described as itching, burning, dyspareunia, and/or vaginal discharge. Aided by vulvoscopy, genital signs were based on visual appearance (colour and surface changes) and palpation (texture and elasticity). Mons pubis, labia majora, labia minora, clitoris, vestibule, frenulum, perineum and perianal area were all examined closely. Genital lesions were defined as papular, erosive-atrophic or hypertrophic, according to the International Society for the Study of the Vulvovaginal Disease (ISSVD) (17) . Examples of VLP and VLS are shown in Fig. 2 . To reach histological confirmation of VLP, one or more biopsies were performed. In the presence of vaginal discharge from bacterial or candidal infection, a suitable treatment was given before performing biopsy.
Histological procedures and characteristics
For diagnosis of OLP and VLP, formalin-fixed and paraffinembedded tissue sections were stained with haematoxylin-eosin and evaluated in a blinded manner by two pathologists (EM and DC). CD3 (pan T) and CD20 (pan B) immuno-stains were performed to confirm the predominance of T lymphocytes (CD3+) over B lymphocytes (CD20+), typical for LP (18) (19) (20) ; no assessment of sub-populations of T lymphocytes (CD4 or CD8) was routinely carried out.
Each case had to meet the inclusion and exclusion criteria. Cases were categorized as "histologically diagnostic of OLP/VLP" only when all three inclusion criteria were present (category 1); "compatible with OLP/VLP" when only two criteria were present (category 2) and "non consistent with OLP/VLP" when less than two criteria were evident (category 3). Only patients classified in category 1 or 2 were included in the study. The inclusion criteria were: (i) signs of "liquefaction degeneration" in the basal cell layer; (ii) presence of welldefined band of cellular infiltration, confined to the superficial part of the connective tissue; and (iii) strong predominance of T lymphocytes in the inflammatory infiltrate (Fig. 3 a) . Each of these histological features was scored: 1=presence; 0=absence. Although criteria used were originally established for OLP, in our study they were considered also for genital lesions, in the absence of criteria more recent than 1909 (21) . Exclusion criteria were the following: (i) epithelial dysplasia (defined as presence of nuclear enlargement and hyperchromatism, increased number of mitotic figures, aberrant mitoses, or dyskeratosis); (ii) absence of epithelial layers (for ulcers or erosions, inadequate sampling); (iii) deep extension of infiltration beyond superficial stroma; (iv) heterogeneous population in inflammatory infiltrate with B lymphocytes, neutrophils or plasma cells; (v) presence of lymphoid follicles in the infiltrate; or (vi) perivascular infiltration.
Cases of VLS were included in the study when they met the following morphological features: (i) homogenization of the dermis with a band of scattered lymphocytes beneath; (ii) spongiosis of basal cell layer; or (iii) loss of rete ridges and thinning of the epithelium (Fig. 3b) .
Statistics
Data were analysed by SPSS 10.0 (Chicago, IL, USA.). The χ 2 test was used to assess statistical differences among categorical variables; Fisher's exact test was used when the frequency observed was less than 5; Student's t-test was used for continuous variables; in all of evaluations p-values ≤ 0.05 were considered statistically significant. In particular, to measure the association level, crude odds ratio and the corresponding test-based 95% confidence interval were calculated. Reference groups were chosen as follows: for symptomatic category, the asymptomatic was chosen as the reference group; for ordinal variable (e.g. age) the first category was chosen as the reference group; for other features, the category with the largest number was chosen as the reference group.
RESULTS
As shown in Fig. 4 , 55 females were enrolled with clinical signs of OLP (mean age 60.7 years, range 33-80 years). In all, 14/55 (26%) patients were dropped from the study. The remaining 41 patients all had histologically confirmed OLP (83% were OLP category 1 and 17% were OLP category 2). Of these 41 patients, 31 showed clinical signs of genital lichenoid lesions. All 31 patients underwent genital biopsy, and 27/31 patients (87%) showed histological confirmation of VLP, VLS, or both: 16/31 (52%) were VLP category 1, 6/31 (19%) were VLP category 2, 3/31 (10%) were VLS, and 2/31 were both VLP and VLS. Four of 31 patients had other diseases. Those with genital involvement (VLP or VLS) showed a wide range in scores equated with degree of narrowing of the vaginal orifice.
After stratifying by whether they experienced genital symptoms, the demographic, clinical and histological features of the 41 patients, are shown for OLP and VLP/ VLS in Tables I and II, respectively. There were no significant associations with the presence of VLP/VLS in terms of the demographic, clinical and histological features of OLP, regardless of genital symptomatology. Only one woman presented a pure "vulvo-gingival" form of LP, with exclusive involvement of both gingival and vulval sites.
Isolated gingival localization was found in only 3/27 (11%) of patients.
DISCUSSION
LP is a muco-cutaneous disorder that can affect several body sites, showing a wide range of clinical variants and symptoms. Yet, a routine team approach by various specialists (i.e. oral medicine practitioner, gynaecologist and dermatologist) has not been adopted. Eisen (3) observed that in many OLP patients with genital symptoms, evaluation by physicians other than dermatologists, often led to misdiagnosis. Furthermore, diagnosis is rarely definitive when based on procurement of biopsy tissue and strict histological criteria.
Since 1869 (9) , when the first report appeared of a patient with LP in different mucosal sites, simultaneous involvement of different mucosal sites was taken into account. There are many case reports about simultaneous oral-genital involvement (4, 12, 13, (22) (23) (24) (25) (26) (27) (28) , but only few systematic studies have reported prevalence data, with frequencies ranging from 3.7% to 19.3% (2-3). Notably, Eisen (3) identified, in a series of 399 women with OLP, 77 cases (19.3%) of vulval and vaginal LP, presenting mainly with erosive or erythematous genital lesions. Interestingly, all of the 77 patients with genital involvement displayed gingival OLP; however, the severity and clinical oral variants were not correlated to the genital involvement. Ramer et al. (23) reported data regarding patients with severe oral lesions and a mild genital disease, as well as patients with asymptomatic gingival involvement but with severe erosive vulvo-vaginal disease.
In the present study, authors assessed frequency of VLP/VLS (87.1%) in OLP patients and verified that there were no demographic, clinical or histological features of OLP that were significantly associated with genital disease. This was contrary to the reported association in the literature of vulvo-vaginal and gingival disease. Indeed, only a few cases of the vulvo-vaginal-gingival syndrome were found (11.1%), suggesting a casual association rather than a well-defined syndrome.
As Eisen reported (3), sometimes this syndrome is not correctly recognized and the affected women suffer the lack of an appropriate medical therapy. Also, in our experience, the majority of women with genital symptoms reported a long history of such symptoms prior diagnosing the condition, suggesting a period of unsolved unspecified problems. Furthermore, all asymptomatic patients with VLS or/and VLP would have had no reason to consult a gynaecologist if not recruited for the study. In fact, unexpectedly, the highest frequency of genital lichen-like lesions was registered in the asymptomatic group (92.3%), but without any statistically significant difference, suggesting that lack of genital symptoms does not exclude per se the involvement of the district.
Previous studies have highlighted the need for histological evaluation in every case in which the features of the history and physical examination are suggestive of (27) propose that the diagnosis of VLP may be based clinically on the presence of vulvo-vaginal signs alone, and the discovery of oral lesions is particularly supportive of this diagnosis. Additionally, they proposed that vulval or vaginal biopsy is generally non-contributory and may be misleading because, in presence of erosion, the histological features are variable. Conversely, in our experience described here, the diagnosis of LP (vulvovaginal or oral) should always be confirmed by biopsy on the basis of a set of reproducible clinical and histopathological criteria; and also, in doubtful cases, additional biopsies should be performed to establish the diagnosis. As mentioned above, many definitions have been proposed to describe a multifocal presentations of LP, from "vulvo-vaginal-gingival syndrome" (12) , to "plurimucosal lichen planus" (13) , to "oro-vaginal-vulvar lichen planus" (28) . In our opinion, the term "plurimucosal lichen planus" used by Bermejo et al. (13) is appropriate only to describe the simultaneous (synchronous or metachronous) sites without specifying gingival or vaginal sites, since they are not always the areas affected. In fact, evaluation of our data (Tables I and II) suggests that no dominant site exists, and several sites may be involved at the same time.
Regarding overlapping syndrome VLP/VLS, some authors (8, 32, 33) have suggested that these two aspects may represent a transitional stage to a unique disease rather than the coexistence of two distinct entities (8) . In our opinion, differential diagnosis between VLP and VLS is difficult, particularly in the late stage of disease when fibrosis aspects, typical of VLS, are sometimes overlapping. Indeed both pictures are based on a similar immunological pathogenetic mechanism.
This cross-sectional study shows a higher frequency of concomitant VLP or/and VLS in women with OLP than previously reported in the literature; yet stringent exclusion histological criteria were applied. On the basis of our data, we suggest that all women with any clinical variant of OLP, even in the absence of genital symptoms, should undergo a thorough multidisciplinary evaluation with a strict protocol for LP diagnosis. Even in the absence of genital signs, long-term surveillance of the same patients should be planned in order to prevent multi-site involvement and possible malignant transformation (34, 35) .
